The association between the development of autoimmune polyglandular syndrome in adults and polymorphism of HLA class II genes and the predisposition to the development of chronic adrenal insufficiency in the context of these syndromes


Cite item

Full Text

Abstract

Aim: to consider association of chronic adrenal insufficiency in patients with APS of adults with polymorphism of class II HLA genes, CTLA-4 and PTPN-22. Materials and methods. The case-control study involved 78 patients with APS 2, 3, 4 types and 109 healthy subjects). Alleles of the HLA class II genes, CTLA-4 and PTPN-22 were identified by the multiprimer allele-specific PCR method. The statistical analysis was carried out using the exact two-sided Fisher test. The association of the chronic adrenal insufficiency in patients with APS was determined by the value of the odds ratio (OR - odd's ratio), the value of 95% confidence interval (95% CI - confidence interval). Results and discussion. Haplotypes DR3-DQ2 (OR = 4.06), DR4-DQ8 (OR = 5.78), genotype DR3/DR4 (OR = 19.7), DQA1 * 0301 allele (OR = 4.27), as well as genotype DQA1 * 0301 / DQA1 * 0501 (OR = 13.89) predispose to the development of APS of adults compared to the control group. APS patients were divided into two groups according to the presence of chronic adrenal insufficiency (APS 2 and 4 types - in one group and type 3 APS in the other group). Haplotype DR3-DQ2 (DRB1 * 17-DQA1 * 0501 -DQB1 * 0201) (OR = 2.6), as well as the genotype DR3/DR4 (OR = 4.28) found the strongest association with the development of adrenal insufficiency in patients with APS of adults. Protective haplotypes DRB1 * 01-DQA1 * 0101-DQB1 * 0501 (p<0.01, OR = 0.07), as well as the DRB1 * 01 allele (p<0.01, OR = 0.08) have been identified with respect to the development of adrenal insufficiency in adult APS patients. Conclusion. Examination of patients with APS of adults without chronic adrenal insufficiency for the presence of protective genes for the development of adrenal insufficiency will allow better predicting the risks of developing of the disease within the syndrome.

About the authors

A A Larina

National Medical Research Center of Endocrinology, Ministry of Health of Russia

Email: doc.Larina@gmail.com
заочный аспирант отд. терапевтической эндокринологии; ORCID: 0000-0003-0622-2141 Moscow, Russia

E A Troshina

National Medical Research Center of Endocrinology, Ministry of Health of Russia

член-корр. РАН, проф., зам. директора Института клинической эндокринологии, руководитель отд. терапевтической эндокринологии Moscow, Russia

O N Ivanova

National Medical Research Center of Endocrinology, Ministry of Health of Russia

к.б.н., в.н.с., зав. лаб. генетики и клинической иммунологии Moscow, Russia

References

  1. Дедов И.И., Мельниченко Г.А., редакторы. Эндокринология: Национальное руководство. Москва: ГЭОТАР-Медиа; 2016. С. 1081-1088. Available from: http://www.rosmedlib.ru/book/ISBN9785970436820.html
  2. Betterle C, Zanchetta R. Update on autoimmune polyendocrine syndromes (APS). Clin Immunol Allergol. 2003;74:9-33.
  3. Erichsen M, Lovas K, Skinningsrud B. Clinical, Immunological, and Genetic Features of Autoimmune Primary Adrenal Insufficiency: Observations from a Norwegian Registry. J Clin Endocr Metab. 2009;94(12):4882-4890. doi: 10.1210/jc.2009-1368
  4. Klein J, Stato A. The HLA System. First of two Parts. N Engl J Med. 2000;343:702-709. doi: 10.1056/nejm200010123431520
  5. Klein J, Stato A. The HLA System. Second of two Parts. N Engl J Med. 2000;343:782-786. doi: 10.1056/nejm200011163432020
  6. Villano M.J.B, Huber A.K, Greenberg D.A, Golden B.K, Concepcion E, Tomer Y. Autoimmune thyroiditis and diabetes: dissecting the joint genetic susceptibility in a large cohort of multiplex families. J Clin Endocr Metab. 2009;94:1458-1466. doi: 10.1210/jc.2008-2193
  7. Brozzetti A, Marzotti S, Tortoioli C, Bini V, Giordano R, Dotta R, Betterle C, de Bellis A, Arnaldi G, Toscano V, Arvat E, Bellastella A, Mantero F, Falorni A. Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta - analysis of European studies. Eur J Endocrinol. 2010;162(2):361-369. doi: 10.1530/eje-09-0618
  8. Myhre A.G, Undelien D.A, Lovas K, et al. Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II association related to clinical features. J Clin Endocr Metab. 2002;87:618-623. doi: 10.1210/jc.87.2.618
  9. Albergoni P, Gazzola M.V, Slanzi E, Carcassi C, Dal Pra C, Moscon A, Betterle C. HLA-DR and DQ associations with autoimmune Addison's disease in Italian patients. Genes Immunity. 2003;4(1):S35.
  10. Erichsen M, Løvås K, Skinningsrud B, Wolff A, Undlien D, Svartberg J, Fougner K, Berg T, Bollerslev J, Mella B, Carlson J, Erlich H, Husebye E. Clinical, Immunological, and Genetic Features of Autoimmune Primary Adrenal Insufficiency: Observations from a Norwegian Registry. J Clin Endocr Metab. 2009;94(12):4882-4890. doi: 10.1210/jc.2009-1368
  11. Huang W, Connor E, Dela Rosa T, Muir A, Schatz D, Silverstein J, Crockett S, She J-X, Maclaren N. Although DR3-DQB1*0201 may be associated with multiple component diseases of the Autoimmune Polyglandular Syndrome,the Human Leukocyte Antigen DR4-DQB1*0302 haplotype is implicated only in beta - cells autoimmunity. J Clin Endocr Metab. 1996;81:2259-2263. doi: 10.1210/jcem.81.7.8675578
  12. Wallaschofski H, Meyer A, Tuschy U, Lohmann T. HLA-DQA1*0301-associated susceptibility for autoimmune polyglandular syndrome type II and III. Horm Metab Res. 2003;35(2):120-124. doi: 10.1055/s-2003-39059
  13. Betterle C, Lazzarotto F, Presotto F. Autoimmune polyglandular syndrome Type 2: the tip of an iceberg? Clin Exp Immunol. 2004;137(2):225-233. doi: 10.1111/j.1365-2249.2004.02561.x
  14. Baker P, Fain P, Kahles H, Yu L, Hutton J, Wenzlau J, Rewers M, Badenhoop K, Eisenbarth G. Genetic determinants of 21-hydroxylase autoantibodies amongst patients of the Type 1 Diabetes Genetics Consortium. J Clin Endocr Metab. 2012;97(8):E1573-8. doi: 10.1210/jc.2011-2824
  15. Kahaly G.J. Polyglandular autoimmune syndromes. Eur J Endocrinol. 2009;161(1):11-20. doi: 10.1530/eje-09-0044
  16. Golden B, Levin L, Ban Y, Concepcion E, Greenberg D.A, Tomer Y. Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes. J Clin Endocr Metab. 2005;90(8):4904-4911. doi: 10.1210/jc.2004-2236
  17. Hansen M.P, Matheis N, Kahaly G.J. Type 1 diabetes and polyglandular autoimmune syndrome: A review. World J Diabetes. 2015;6(1):67-79. doi: 10.4239/wjd.v6.i1.67
  18. Kahles H, Ramos-Lopez E, Lange B, Zwermann O, Reincke M, Badenhoop K. Sex - specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto’s thyroiditis or Addison’s disease in the German population. Eur J Endocrinol. 2005;153(6):895-899. doi: 10.1530/eje.1.02035
  19. Velaga M.R, Wilson V, Jennings C.E, Owen C.J, Herington S, Donaldson P.T, Ball S.G, James R.A, Quinton R, Perros P, Pearce S.H. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves’ disease. J Clin Endocr Metab. 2004;89:5862-5865. doi: 10.1210/jc.2004-1108

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies